Cite Filings / CTY / 0001193125-26-432028

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

CITY THERAPEUTICS, INC. Filed 2026-10-26 Acc 0001193125-26-432028

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-10-26 SCHEDULE 13D Beneficial Ownership Report
2026-10-26 SCHEDULE 13G Statement of Beneficial Ownership
2026-10-22 SCHEDULE 13G Statement of Beneficial Ownership
2026-10-19 4 10% owner bought 170,000 shares at $18.00 ($3,060,000)
2026-10-19 4 Director bought 170,000 shares at $18.00 ($3,060,000)
2026-10-19 4 Options or other derivatives
2026-10-19 4 Options or other derivatives

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…